Vendor, San Antonio, TX
Oncobiomix Inc.
UEI PSUGLD3EPBJ5, CAGE 9PHF7
1 award and $400,000 obligated between September 4, 2024 and March 6, 2025, 100% under full and open competition, against 7.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $400,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00067Definitive Contract, September 4, 2024, Full and Open Competition After Exclusion of Sources, 7 offers | NIH NCINational Institutes of Health | Topic Number: 458 Small Business Innovation Research (Sbir) Phase I Oncobiomix: Microbiome-Based Test for Prostate Cancer RiskNAICS 541715, PSC AN12 | $400,000 |
- Places of performance
- Texas
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards